These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27627783)

  • 1. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
    Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
    Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TACC2 (transforming acidic coiled-coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation.
    Onodera Y; Takagi K; Miki Y; Takayama K; Shibahara Y; Watanabe M; Ishida T; Inoue S; Sasano H; Suzuki T
    Cancer Med; 2016 Aug; 5(8):1973-82. PubMed ID: 27333920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells.
    Lau WM; Doucet M; Huang D; Weber KL; Kominsky SL
    Biochem Biophys Res Commun; 2013 Jul; 437(2):261-6. PubMed ID: 23811274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.
    Tang Z; He G; Xu J; Zhongfu L
    J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
    van Agthoven T; Sieuwerts AM; Veldscholte J; Meijer-van Gelder ME; Smid M; Brinkman A; den Dekker AT; Leroy IM; van Ijcken WF; Sleijfer S; Foekens JA; Dorssers LC
    Br J Cancer; 2009 Dec; 101(11):1824-32. PubMed ID: 19904269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
    Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP
    Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CITED2 affects leukemic cell survival by interfering with p53 activation.
    Mattes K; Berger G; Geugien M; Vellenga E; Schepers H
    Cell Death Dis; 2017 Oct; 8(10):e3132. PubMed ID: 29072699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis.
    Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2011 Sep; 226(9):2415-28. PubMed ID: 21660965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
    Jayaraman S; Doucet M; Kominsky SL
    Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence.
    Chou YT; Hsieh CH; Chiou SH; Hsu CF; Kao YR; Lee CC; Chung CH; Wang YH; Hsu HS; Pang ST; Shieh YS; Wu CW
    Cell Death Differ; 2012 Dec; 19(12):2015-28. PubMed ID: 22814619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.
    Yang YF; Lee YC; Wang YY; Wang CH; Hou MF; Yuan SF
    Kaohsiung J Med Sci; 2019 Jul; 35(7):408-416. PubMed ID: 31001932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
    Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
    Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα.
    Jayaraman S; Doucet M; Lau WM; Kominsky SL
    Mol Cancer Res; 2016 Aug; 14(8):730-9. PubMed ID: 27216153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
    Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of XB130 in human ductal breast cancer.
    Li J; Sun W; Wei H; Wang X; Li H; Yi Z
    Int J Clin Exp Pathol; 2015; 8(5):5300-8. PubMed ID: 26191231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
    Sato A; Takagi K; Miki Y; Yoshimura A; Hara M; Ishida T; Sasano H; Suzuki T
    Histol Histopathol; 2019 Dec; 34(12):1365-1375. PubMed ID: 31149728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
    Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
    Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
    Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
    Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
    Liu YC; Chang PY; Chao CC
    Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
    Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
    J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.